⚲
|
Sorrento Therapeutics | |
---|---|
Ticker | SRNE |
CIK # | 0000850261 |
CUSIP | 83587F202 |
Sector | Trade & Services |
Industry | Services-Commercial Physical & Biological Research |
Phone | 8582103700 |
Address | 6042 Cornerstone Ct West Suite B San Diego, CA 92121 |
Source | [EDGAR] |
Market Cap, 13F ($) |
---|
Business |
---|
Sorrento Therapeutics, Inc. (Nasdaq: SRNE), together with its subsidiaries (collectively, the "Company", "we", "us" and "our") is a clinical stage and commercial biopharma company focused on delivering innovative and clinically meaningful therapies to patients and their families to address unmet medical needs. We also have programs assessing the use of our technologies and products in autoimmune, inflammatory and neurodegenerative diseases. At our core, we are an antibody-centric company and leverage our proprietary G-MAB™ library and targeted delivery modalities to generate the next generation of cancer therapeutics. Our fully human antibodies include PD-1, PD-L1, CD38, CD123, CD47, CTLA-4, c-MET, VEGFR2, CCR2 and CD137 among others. Our vision is to leverage these antibodies in conjunction with proprietary targeted delivery modalities to generate the next generation of cancer therapeutics. These modalities include proprietary chimeric antigen receptor T-cell therapy ("CAR-T"), dimeric antigen receptor T-cell therapy ("DAR-T"), antibody drug conjugates ("ADCs") as well as bispecific antibody approaches. We acquired Sofusa®, a revolutionary drug delivery system, in July 2018, which delivers biologics directly into the lymphatic system to potentially achieve improved efficacy and fewer adverse effects than standard parenteral immunotherapy. Additionally, our majority owned subsidiary, Scilex Holding Company ("Scilex Holding"), acquired the assets of Semnur Pharmaceuticals, Inc. ("Semnur") in March 2019. Semnur's SEMDEXATM (SP-102) compound has the potential to become the first FDA-approved epidural steroid product for the treatment of sciatica. |
CIK | Filing | 2011 - 2023 |
---|---|---|
[0000850261] | 10-K | |
[0000850261] | 10-Q | |
[0000850261] | 3 | |
[0000850261] | 4 | |
[0000850261] | 5 | |
[0000850261] | 8-K | |
[0000850261] | D | |
[0000850261] | SC 13D | |
[0000850261] | SC 13G |